Evrys Bio Awarded $34 Million from DOD to Develop a Single Drug Simultaneously Effective Against Multiple Lethal Viruses

NEXT STORY
HUTCHMED Announces First Commercial Sale of ORPATHYS® in China, Triggering a US$25 million Milestone Payment from AstraZeneca
PREV STORY
Chlamydia Infections Pipeline | A Clinical Trials Analysis Report 2021 | DelveInsight
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

USPTO rejects new reexamination request against Celyad’s US Patent for Production of Allogeneic TCR-Deficient CAR-T Cells

MONT-SAINT-GUIBERT, Belgium, March 16, 2017 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a ...

author_avatar
NASDAQ Market News

Generex Biotechnology Announces Webcast and Invites All Shareholders to See and Listen to the Corporate Presentation from the 21st Annual H.C. Wainwright Global Healthcare Investment Conference

author_avatar
NASDAQ Market News

Fairmont Hospital Announces RehabCare Partnership to Enhance Rehabilitation Services

SAN LEANDRO, Calif., Jan. 20, 2015 (GLOBE NEWSWIRE) -- Fairmont Hospital, a member of ...

author_avatar
NASDAQ Market News